Logo - springer
Slogan - springer

Springer Healthcare | Neurology and Therapy (Editorial Board)

Neurology and Therapy

Neurology and Therapy

Co-Editor-in-Chief: M.N. Sabbagh; A. Bertolotto

ISSN: 2193-8253 (print version)
ISSN: 2193-6536 (electronic version)

Journal no. 40120

Editors in Chief

Europe: Antonio Bertolotto, San Luigi Gonzaga Hospital, Turin, Italy
USA: Marwan N. Sabbagh, Cleveland Clinic Luo Ruvo Center for Brain Health, Las Vegas, NV, USA                                          

Editorial Board

Cognitive Disorders
Bruno Dubois, Sorbonne University, Paris, France
Paul Francis, King's College London, London, UK
Samuel Gandy, Icahn School of Medicine at Mount Sinai, Department of Neurology, New York, NY, USA
Dawn Langdon, Royal Holloway, University of London, Egham, Surrey, UK
Marwan N. Sabbagh, Cleveland Clinic Luo Ruvo Center for Brain Health, Las Vegas, NV, USA

Epilepsy & Seizures
Renzo Guerrini, Universita degli Studi di Firenze, Pediatric Neurology Unit and Laboratories, Florence, Italy
Ronald P. Lesser, Johns Hopkins University, Baltimore, MD, USA
Eugen Trinka, Dept. of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg, Austria

Headache & Migraine
Stefan Evers, Krankenhaus Lindenbrunn Coppenbrugge, Germany
Mark Obermann, Department of Neurology, University of Duisburg-Essen, Essen, Germany
Stewart Tepper, Geisel School of Medicine at Dartmouth, Hanover, NH, USA

Movement Disorders
Thomas Müller, Department of Neurology, St. Joseph Hospital, Berlin, Germany
Olivier Rascol, Department of Clinical Pharmacology, University Hospital of Toulouse, Toulouse, France
Heinz Reichmann, Department of Neurology, University of Dresden, Dresden, Germany
Anthony Schapira, Department of Clinical Neurosciences, UCL Institute of Neurology, London, UK
Leonard Verhagen-Metman, Rush University Medical Center, Chicago, IL, USA

Multiple Sclerosis
Rina Aharoni, Immunology Department, The Weizmann Institute of Science, Rehovot, Israel
Antonio Bertolotto, San Luigi Gonzaga Hospital, Turin, Italy
Cris Constantinescu
, University of Nottingham, Nottingham, UK
Yara Fragoso, Universidade Metropolitana de Santos, São Paulo, Brazil
Sten Fredrikson
, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
Angelo Ghezzi, Gallarate Hospital, Multiple Sclerosis Study Center, Gallarate, Italy
Hans-Peter Hartung, Heinrich Heine Universität, Düsseldorf, Germany
Reinhard Hohlfeld, Ludwig-Maximilian-University Munich, Clinic Großhadern, Inst. of Clinical Neuroimmunology, Munich, Germany
Guillermo Izquierdo, Hospital Universitario Virgen Macarena, Seville, Spain
Bernd C. Kieseier
, Department of Neurology, Heinrich Heine University, Düsseldorf, Germany
Christine Lebrun-Frénay, Department of Neurology, University Hospital of Nice, Nice, France
Celia Oreja-Guevara, Hospital Clinico San CarlosMadrid, Spain
Francesco Patti, Universita degli Studi di CataniaCatania, Italy
J. Theodore Phillips, Multiple Sclerosis Center at Texas Neurology, Dallas, TX, USA
Maria A. Rocco, Universita Vita-Salute San Raffaele, Milan, Italy

Neuroimaging
Federica Agosta, Universita Vita-Salute San Raffaele, Milan, Italy
Juan M. Gorriz, Universidad de Granada, Spain
Matilde Inglese, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Maria A. Rocca, Universita Vita-Salute San Raffaele, Milan, Italy
Andrew J. Saykin
, Indiana University School of Medicine, Indianapolis, IN, USA

Neurological Infections
Peter Kennedy, Inst. of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, UK
Johann Sellner, Dept. of Neurology, Christian Doppler Medical Center, Paracelsus Medical University Salzburg, Austria

Neuropathology
Herbert Budka, Medical University Vienna, Austria
Howard E. Gendelman,
University of Nebraska, Omaha, Nebraska, USA

Mental Health and Wellbeing
Yoram Barak, Israel Dunedin School of Medicine, Dunedin, New Zealand
Leslie Citrome, New York Medical College, Valhalla, NY, USA
Dawn Langdon, Royal Holloway, University of London, Egham, Surrey, UK

Sleep Disorders
Alon Avidan, Dept. of Neurology, University of California Los Angeles Sleep Disorders Center, Los Angeles, CA, USA

Stroke
Natan Bornstein, Shaare-Zedek Medical Center, Jerusalem, Israel
Christian T. Ruff, Brigham and Women's Hospital, Boston, MA, USA
Yukito Shinohara, Tachikawa Hospital, Japan


Advisory Board

Jean-Philippe Azulay, Brandon R. Barton, Virginia Casado, Randolph Evans, Maria Luisa Figueira, Charly Gaul, Valentina Lucia La Rosa, Norah Lincoff, Elena H. Martinez-Lapiscina, Katherine McMillan, Paul Newhouse, Iris-Katharina Penner, Janaine Cunha Polese, Andrea Poretti, Patricio Riva Posse, Jaume Sastre-Garriga, Mary Ellen Stoykov, François Tison, Kayihan Uluc, Zhongya Wang, Michael Zvolensky


Recruitment

As Neurology and Therapy continues to go from strength to strength, we are constantly looking to expand our esteemed Editorial and Advisory Reviewer Boards, and include within them individuals who may want to further their editorial experience within their range of expertise. With this in mind, if you would like to represent your research community as part of our boards, please email kirstie.edwards@springer.com with the following information: Name, title (Mr/Mrs/Dr/Prof), profession, affiliation/institution or company, country, telephone number, area(s) of expertise, and a brief Curriculum Vitae (CV).

For authors and editors

  • Aims and Scope

    Aims and Scope

    Close

    Aims and Scope

    Neurology and Therapy aims to provide reliable and inclusive, rapid publication for all therapy related research for neurological indications, supporting the timely dissemination of research with a global reach, to help advance scientific discovery and support clinical practice.

    Neurology and Therapy is an international, open access, peer reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world and health outcomes research around the discovery, development, and use of neurological and psychiatric  therapies, (also covering surgery and devices). Studies relating to diagnosis, pharmacoeconomics, public health, quality of life, and patient care, management, and education are also welcomed.

    The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, case reports, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Neurology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research. 

    Rapid Publication

    The journal’s rapid publication timelines aim for a peer review decision within 2 weeks of submission. If an article is accepted, it will be published online 3-4 weeks from acceptance. These rapid timelines are achieved through the combination of a dedicated in-house editorial team, who closely manage article workflow, and an extensive Editorial and Advisory Board who assist with rapid peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model, this allows for the rapid and efficient communication of the latest research and reviews to support scientific discovery and clinical practice.

    Personal Service

    The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning that authors will always have a personal point of contact able to update them on the status of their manuscript.  The editorial team check all manuscripts to ensure that articles conform to the most recent COPE and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. We also encourage pre-submission enquiries and are always happy to provide a confidential assessment of manuscripts.  

    Enhanced Digital Features

    Neurology and Therapy is able to publish a range of additional enhanced digital features designed to increase visibility, readership, and the educational value of the content. Every paper is accompanied by a bulleted summary slide, giving a time-efficient overview of the article’s key points for a wider readership. Other types of enhanced digital features are also possible such as slide sets, videos and video abstracts, infographics, podcasts and animations. All enhanced digital features are open access and are peer reviewed to the same high standard as the article itself. They can either be submitted at the same time as the manuscript or can be submitted retrospectively, and there is no additional cost to publish these features.

    By having a choice of media for articles (not limited to text, figures and tables alone), readers may receive information more efficiently, whilst being reassured that the content has undergone the same rigorous peer review as the original article. Offering succinct multimedia formats can support time-pressed healthcare professionals in keeping on top of recently published research.

    For questions relating specifically to enhanced digital features, please contact adisdigitalfeatures@springer.com.

    Plain Language Summaries

    Articles published in Neurology and Therapy can be accompanied by Plain Language Summaries to assist non-experts (including non-specialists, patients, caregivers and others) in understanding important medical advances. These summaries can help the content to reach a broader audience thus supporting the effective dissemination of research.

    Peer Review Process

    Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

    At least two extensive reviews are required to make the editorial decision. Where reviews conflict, an Editorial Board Member will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed. Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised, it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case-by-case basis and should be sent to the journal editor, and authors are welcome to make rebuttals against individual reviewer comments, if appropriate.

    Copyright

    Neurology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.

    Publication Fees

    Upon acceptance of an article, authors will be required to pay the article processing charge of €340/ $380 per typeset page, which includes the rapid publication, open access, and other features mentioned above. The journal will consider fee discounts and waivers for developing countries on a case-by-case basis.  

    Contact

    For more information about the journal, including pre-submission enquiries, please contact Kirstie.edwards@springer.com.

  • Submit Online
  • Instructions for Authors (pdf, 1.1 MB)
  • Compliance with Ethical Policies
  • Author Disclosure Form (docx, 45 kB)
  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information

    Close

    Copyright Information

    Open Access Neurology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0

    Journal ownership: Springer Healthcare

    Copyright of articles: © The Author(s)

Alerts for this journal

 

Get the table of contents of every new issue published in Neurology and Therapy.


Additional information